WebDuring her tenure there, she grew the medical device offering from clinical operations to the full spectrum of development, including scientific consulting and regulatory. Rachel was also the Vice President of Clinical Operations for Biom’up and took HEMOBLAST Bellows from the lab through to commercialization. Web(HEMOBLAST™ Bellows) compared to a control device, absorbable gelatin sponge USP with thrombin. Indication HEMOBLASTTM Bellows is intended for use in surgical procedures as an adjunct to hemostasis when control of bleeding by conventional procedures is ineffective or impractical, except in neurosurgical, ophthalmic, and …
BusinessWire - Biom Up SA (BUP) Biom’up reçoit le …
WebHemoblast Bellows EMA/CHMP/154036/2024 Page 2/4 pivotal, clinical investigation evaluation the safety and efficacy of HEMOBLAST™ Bellows in cardiothoracic, … Web2 feb. 2024 · The purpose of this clinical investigation in open, elective, spine surgery is to collect data to support the removal of the neurosurgical exclusion from the currently approved indication for the use of HEMOBLAST™ Bellows. This study is primarily designed to assess safety of the device for use in spine surgery, although efficacy information ... agent commercial multicarte
Evaluation of Safety of HEMOBLAST Bellows in Spine Surgery
Web20 mei 2024 · Biom’up prévoit un chiffre d’affaires global 2024 pour HEMOBLAST Bellows de l’ordre de 4,0 à 4,5 M€ Les dépenses... 09/05/2024 18:09:36 Cookie Policy +44 (0) 203 8794 460 Free Membership Login WebPost-market evaluation of HEMOBLASTTM Bellows performance and safety in open gynecological, urological, ENT, head and neck, and vascular surgery: Erkrankung: Geschlechtsorgane: Krebserkrankungen der weiblichen Geschlechtsorgane: sonstige Studien für Krebserkrankungen der weiblichen Geschlechtsorgane WebBUP Biom Up SA Biom’up : Une nouvelle publication souligne l’utilisation d’ HEMOBLASTTM Bellows en chirurgie cardiovasculaire maosen リュック